Select Publications
Journal articles
2023, 'Connecting the Dots of Care: A pilot study linking Aboriginal and/or Torres Strait Islander peoples with diabetes care in hospital, using hospital pharmacists', Exploratory Research in Clinical and Social Pharmacy, 12, http://dx.doi.org/10.1016/j.rcsop.2023.100351
,2023, 'SGLT2 Inhibitor-Induced Ketoacidosis in a Patient Without Diabetes', Diabetes Care, 47, pp. e4 - e5, http://dx.doi.org/10.2337/dc23-1903
,2023, 'Connecting the dots of care: Linking Aboriginal and Torres Strait Islander people with diabetes care in hospital using hospital pharmacists', Research in Social and Administrative Pharmacy, 19, pp. 4 - 4, http://dx.doi.org/10.1016/j.sapharm.2023.04.012
,2022, 'Tip of the iceberg: are we missing undiagnosed patients with maturity onset diabetes of the young?', Internal Medicine Journal, 52, pp. 2011 - 2012, http://dx.doi.org/10.1111/imj.15948
,2021, 'Roux-en-Y gastric bypass and gastric sleeve surgery result in long term bone loss', International Journal of Obesity, 45, pp. 235 - 246, http://dx.doi.org/10.1038/s41366-020-00660-x
,2018, 'Interrogation of a longitudinal, national pharmacy claims dataset to explore factors that predict the need for add-on therapy in older and socioeconomically disadvantaged Australians with type 2 diabetes mellitus patients (T2DM)', European Journal of Clinical Pharmacology, 74, pp. 1327 - 1332, http://dx.doi.org/10.1007/s00228-018-2506-5
,2018, 'Relative contributions of lean and fat mass to bone mineral density: Insight from Prader-Willi syndrome', Frontiers in Endocrinology, 9, http://dx.doi.org/10.3389/fendo.2018.00480
,2017, 'The value of the sulfonylurea gliclazide compared to newer oral antidiabetic agents', Therapeutische Umschau, 74, pp. 423 - 431, http://dx.doi.org/10.1024/0040-5930/a000936
,2017, 'Fermentable carbohydrate stimulates FFAR2-dependent colonic PYY cell expansion to increase satiety', Molecular Metabolism, 6, pp. 48 - 60, http://dx.doi.org/10.1016/j.molmet.2016.10.011
,2016, 'Trends in metformin utilisation and dose appropriateness in Australia', European Journal of Clinical Pharmacology, 72, pp. 1489 - 1496, http://dx.doi.org/10.1007/s00228-016-2117-y
,2016, 'Vitamin D levels in primary growth hormone deficiency disorder Prader–Willi syndrome', Endocrine, 53, pp. 619 - 620, http://dx.doi.org/10.1007/s12020-016-0889-6
,2016, 'Randomised clinical study: inulin short-chain fatty acid esters for targeted delivery of short-chain fatty acids to the human colon', Alimentary Pharmacology and Therapeutics, 44, pp. 662 - 672, http://dx.doi.org/10.1111/apt.13749
,2015, 'Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults', Gut, 64, pp. 1744 - 1754, http://dx.doi.org/10.1136/gutjnl-2014-307913
,2015, 'Postprandial metabolism in adults with prader-willi syndrome', Obesity, 23, pp. 1159 - 1165, http://dx.doi.org/10.1002/oby.21041
,2015, 'Effects of Elevating Colonic Propionate on Liver Fat Content in Adults with Non‐Alcoholic Fatty Liver Disease', The FASEB Journal, 29, http://dx.doi.org/10.1096/fasebj.29.1_supplement.385.2
,2015, 'Effects of elevating colonic propionate on liver fat content in overweight adults with non-alcoholic fatty liver disease: a pilot study', Proceedings of the Nutrition Society, 74, http://dx.doi.org/10.1017/s0029665115000452
,2014, 'The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism', Nature Communications, 5, http://dx.doi.org/10.1038/ncomms4611
,2014, 'Targeted delivery of propionate to the colon stimulates the release of anorectic gut hormones and suppresses appetite in humans', Proceedings of the Nutrition Society, 73, http://dx.doi.org/10.1017/s0029665114000299
,2014, 'Targeted delivery of propionate to the human colon prevents body weight and intra-abdominal adipose tissue gain in overweight adults', Proceedings of the Nutrition Society, 73, http://dx.doi.org/10.1017/s0029665114000366
,2013, 'Coadministration of glucagon-like peptide-1 during glucagon infusion in humans results in increased energy expenditure and amelioration of hyperglycemia', Diabetes, 62, pp. 1131 - 1138, http://dx.doi.org/10.2337/db12-0797
,2013, 'Immune cell-mediated inflammation and the early improvements in glucose metabolism after gastric banding surgery', Diabetologia, 56, pp. 2564 - 2572, http://dx.doi.org/10.1007/s00125-013-3033-7
,2013, 'Postprandial cardiac autonomic function in Prader-Willi syndrome', Clinical Endocrinology, 79, pp. 128 - 133, http://dx.doi.org/10.1111/cen.12084
,2013, 'Reduced arterial stiffness after weight loss in obese type 2 diabetes and impaired glucose tolerance: The role of immune cell activation and insulin resistance', Diabetes and Vascular Disease Research, 10, pp. 40 - 48, http://dx.doi.org/10.1177/1479164112443375
,2012, 'Obesity is associated with activated and insulin resistant immune cells', Diabetes/metabolism research and reviews, 28, pp. 447 - 454, http://dx.doi.org/10.1002/dmrr.2302
,2011, 'Dietary starch and fiber: potential benefits to body weight and glucose metabolism', Diabetes Management, 1, pp. 521 - 528, http://dx.doi.org/10.2217/dmt.11.40
,2011, 'In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels', Neuropeptides, 45, pp. 301 - 307, http://dx.doi.org/10.1016/j.npep.2011.06.001
,2010, 'The Effects of Weight Loss and Gastric Banding on the Innate and Adaptive Immune System in Type 2 Diabetes and Prediabetes', Endocrinology, 151, pp. 2396 - 2396, http://dx.doi.org/10.1210/endo.151.5.9992
,2010, 'Critical role for ghrelin, but not PYY or GLP-1, in Prader–Willi syndrome hyperphagia', Obesity Research & Clinical Practice, 4, pp. S6 - S6, http://dx.doi.org/10.1016/j.orcp.2010.09.013
,2008, 'Abnormal postprandial PYY response in insulin sensitive nondiabetic subjects with a strong family history of type 2 diabetes', International Journal of Obesity and Related Metabolic Disorders, 32, pp. 943 - 948, http://dx.doi.org/10.1038/ijo.2008.24
,2007, 'Potential antiinflammatory role of insulin via the preferential polarization of effector T cells toward a T helper 2 phenotype', Endocrinology, 148, pp. 346 - 353
,2005, 'Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free cortisol and overnight dexamethasone suppression test', Journal of Clinical Endocrinology and Metabolism, 90, pp. 5730 - 5736, http://dx.doi.org/10.1210/jc.2004-2264
,2003, 'Dizziness and arterial hypertension in a younger patient: A 42-year-old self-employed heating engineer', Praxis, 92, pp. 821 - 822, http://dx.doi.org/10.1024/0369-8394.92.17.821
,2003, 'Vertigo and arterial hypertension in younger patients. Hyperaldosteronism (Conn syndrome) in diastolic arterial hypertension, chronic hypokalemia, right adrenal gland adenoma', Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 92, pp. 821 - 822
,